Dexcom (DXCM) Receivables (2010 - 2026)

Dexcom (DXCM) has 17 years of Receivables data on file, last reported at $1.1 billion in Q1 2026.

• Receivables for Q1 2026 came in at $1.1 billion, down 5.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 5.5% YoY), and the FY2025 annual result was $1.2 billion, up 20.78% from the prior year.
• Receivables eased to $1.1 billion in Q1 2026 per DXCM's latest filing, from $1.2 billion in the prior quarter.
• Over five years, Receivables peaked at $1.4 billion in Q2 2025 and troughed at $554.8 million in Q1 2022.
• A 5-year average of $917.0 million and a median of $981.9 million in 2023 frame the typical range for Receivables.
• The sharpest annual moves came in 2024 and 2026: Receivables soared 53.12% in 2024, then retreated 5.5% in 2026.
• A 5-year view of Receivables shows it stood at $722.3 million in 2022, then soared by 35.94% to $981.9 million in 2023, then gained by 3.97% to $1.0 billion in 2024, then climbed by 20.78% to $1.2 billion in 2025, then dropped by 10.34% to $1.1 billion in 2026.
• Business Quant data shows DXCM's Receivables at $1.1 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.1 billion in Q3 2025.